Tesamorelin
WHAT IT IS
A prescription peptide therapy that supports natural growth hormone signaling, body composition, and metabolic wellness.
BEST FOR
Body composition • Lean-mass goals • Recovery support • Metabolic wellness • Abdominal fat support
HOW IT'S USED
Subcutaneous injection • Dose and schedule personalized to your treatment plan
WHY CHOOSE IT
A targeted, provider-guided option for patients who want to support their body’s natural GH pathway and body-composition goals.
$ 299.00 USD
Activate your natural growth-hormone pathway. Elevate your body-composition goals.
Buy Now
Description
Molecular Profile
Tesamorelin
Egrifta — Synthetic GHRH analog
Chemical basis GHRH(1–44) with a trans-3-hexenoic acid modification at the N-terminus Modified for stability against enzymatic degradation
Class 44-amino-acid synthetic peptide BLA classified Biologics License Application — not NDA
Form Subcutaneous injectable Daily dosing Weekly reconstitution in the newer F8 / Egrifta WR formulation
Brand names Egrifta 2010 Egrifta SV 2019 Egrifta WR 2025 F8 formulation approved 2025
Origin Developed by Theratechnologies; FDA-approved November 2010 FDA Approved
HOW IT WORKS

Tesamorelin is a growth hormone-releasing hormone analog that signals the pituitary gland to increase your body's own release of growth hormone.

This naturally increases downstream IGF-1 signaling, which plays an important role in metabolism, body composition, tissue maintenance, and other growth-hormone–dependent processes.

Because Tesamorelin works through your body's existing hormonal pathway, it offers a more targeted approach to supporting healthy growth-hormone activity rather than supplying growth hormone directly.

WHAT TO EXPECT

With consistent treatment and a personalized wellness plan, Tesamorelin may support:

• Improved body-composition goals
• A leaner body profile
• Healthy fat metabolism
• Lean-mass support
• Recovery and physical resilience
• Metabolic wellness
• Healthy growth-hormone and IGF-1 activity

Changes are typically gradual, making consistency with treatment, nutrition, movement, and lifestyle especially important.

Your provider can adjust your treatment plan based on your goals, laboratory results, and individual response.

BEFORE YOU START

Your provider will review your medical history, medications, blood sugar, relevant laboratory results, and treatment goals before prescribing Tesamorelin.

Discuss any history of cancer, pituitary conditions, diabetes or blood-sugar concerns, pregnancy, or previous reactions to growth-hormone–related therapies. IGF-1 and glucose levels may require monitoring during treatment.

Prescription required.

Similar Products